eTheRNA Immunotherapies NV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:eTheRNA Immunotherapies NV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11035
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ETheRNA Immunotherapies NV (eTheRNA) is a developer of novel immunotherapies for the treatment of cancers and infectious diseases. The company’s pipeline products include mRNA-based immunotherapies for various indications such as melanoma, triple negative breast cancer and infectious diseases. It provides preclinical and clinical proof to support further development of TriMix technology. eTheRNA also develops drugs for infectious diseases such as influenza, pneumonia, tuberculosis, Lyme disease, HIV and AIDS et cetera. The company also provides contract manufacturing services. It has collaborative partnerships with pharma companies for its research operations. eTheRNA is headquartered in Antwerp, Belgium.

eTheRNA Immunotherapies NV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
eTheRNA Raises USD27 Million in Series A Financing 10
Partnerships 12
Mymetics Enters into Research Collaboration Agreement with eTheRNA 12
PCI Biotech Enters Research Agreement with eTheRNA immunotherapies 13
Licensing Agreements 14
eTheRNA Enters into Licensing Agreement with Vrije Universiteit Brussel 14
eTheRNA Immunotherapies NV – Key Competitors 15
eTheRNA Immunotherapies NV – Key Employees 16
eTheRNA Immunotherapies NV – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Sep 25, 2017: eTheRNA immunotherapies Awarded €1 Million Grant From Flanders Innovation & Entrepreneurship to Further Upgrade its State-of-the-art Production Process for TriMix mRNA Immunotherapies 18
Clinical Trials 19
Mar 19, 2018: eTheRNA completes enrolment of low dose cohort for Phase 1b study of TriMix mRNA-based cancer specific immunotherapy (ECI-006) in melanoma 19
Jun 30, 2017: etherna Advances in-vivo MRNA Cancer Immunotherapy Into First Oncology Clinical Studies 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Key Facts 2
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
eTheRNA Immunotherapies NV, Deals By Therapy Area, 2012 to YTD 2018 8
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
eTheRNA Raises USD27 Million in Series A Financing 10
Mymetics Enters into Research Collaboration Agreement with eTheRNA 12
PCI Biotech Enters Research Agreement with eTheRNA immunotherapies 13
eTheRNA Enters into Licensing Agreement with Vrije Universiteit Brussel 14
eTheRNA Immunotherapies NV, Key Competitors 15
eTheRNA Immunotherapies NV, Key Employees 16
eTheRNA Immunotherapies NV, Other Locations 17

List of Figures
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
eTheRNA Immunotherapies NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[eTheRNA Immunotherapies NV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sultan Center Food Products Co. KSC (SULTAN):企業の財務・戦略的SWOT分析
    Sultan Center Food Products Co. KSC (SULTAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • National Oilwell Varco Inc (NOV)-石油・ガス分野:企業M&A・提携分析
    Summary National Oilwell Varco, Inc. (NOV) designs, manufactures and services a broad range of drilling and well servicing equipment and components for the oil and gas sector. Its offerings include rig systems, wellbore technologies, and completion and production technologies. Its product line compr …
  • Israel Chemicals Ltd.:企業の戦略・SWOT・財務情報
    Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report Summary Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • High Peak Royalties Limited (HPR)-エネルギー分野:企業M&A・提携分析
    Summary High Peak Royalties Limited (High Peak) is a utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The company has r …
  • Baker Hughes, a GE Co LLC:企業の戦略的SWOT分析
    Baker Hughes, a GE Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ana Holdings Inc
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pfizer Inc (PFE):企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Empire District Electric Company:企業の戦略的SWOT分析
    The Empire District Electric Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Cerner Corp (CERN):企業の財務・戦略的SWOT分析
    Cerner Corp (CERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cellnovo Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cellnovo Ltd (Cellnovo), formerly Starbridge Systems Ltd is a provider of conventional diabetes care technology solutions. The company offers mobile diabetes management systems such as insulin patch pump, cellular-enabled wireless touchscreen handset with integrated blood glucose meter, acti …
  • Sunstar Holding AG:企業の戦略・SWOT・財務情報
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Highmark Inc-製薬・医療分野:企業M&A・提携分析
    Summary Highmark Inc (Highmark), a subsidiary of Highmark Health, is a provider of healthcare insurance solutions. The company underwrites various indemnities and offers healthcare insurance products to individuals, families, groups, companies and federal employees. In addition, the company provides …
  • National Bank of Greece SA:企業の戦略・SWOT・財務情報
    National Bank of Greece SA - Strategy, SWOT and Corporate Finance Report Summary National Bank of Greece SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Akonni Biosystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray reader …
  • The Hokuetsu Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Hokuetsu Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Hokuetsu Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Beijing Enterprises Holdings Limited:戦略・SWOT・企業財務分析
    Beijing Enterprises Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Beijing Enterprises Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Kimco Realty Corporation (KIM):企業の財務・戦略的SWOT分析
    Kimco Realty Corporation (KIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Berkshire Hathaway Inc:企業の戦略・SWOT・財務分析
    Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Chubu Electric Power Co Inc (9502):企業の財務・戦略的SWOT分析
    Chubu Electric Power Co Inc (9502) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Antibe Therapeutics Inc (ATE):企業の財務・戦略的SWOT分析
    Summary Antibe Therapeutics Inc (Antibe), formerly Ontario Inc, is a biotechnology company that designs and develops therapies for the treatment of pain and inflammation. The company’s lead compound ATB-346, an anti-inflammatory drug, is designed against chronic pain and inflammation. It is investig …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆